We are live on ! Find out more
BFRIW icon

Biofrontera

6 hedge funds and large institutions have $19.8K invested in Biofrontera in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $12.4K → $19.8K (+$7.41K)

10.33% more ownership

Funds ownership: 2.28%12.61% (+10%)

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$16.3K -$2.11K -25,000 -14%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$1.24K +$996 +11,799 New
TSS
3
Two Sigma Securities
New York
$1.06K -$8 -100 -1%
CS
4
Clear Street
New York
$972 -$17 -200 -2%
Osaic Holdings
5
Osaic Holdings
Arizona
$110
US Bancorp
6
US Bancorp
Minnesota
$105
UBS Group
7
UBS Group
Switzerland
-$54 -891 Closed

BFRIW Hedge Fund Activity: Q2 2025 in Review

6 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q2 2025, worth a combined $19.8K — up 60% from $12.4K a quarter earlier.

Fund positioning in BFRIW was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $996. The largest seller was Bard Associates, cutting an estimated $2.11K.

  • 6 institutional investors held Biofrontera (BFRIW) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $19.8K of Biofrontera stock for Q2 2025, up 60% quarter-over-quarter.
  • 1 fund opened new Biofrontera positions in Q2 2025 and 1 closed out, a net change of 0 holders.
  • The largest Biofrontera buyer in Q2 2025 was Susquehanna International Group, an estimated $996 added.
  • The largest Biofrontera seller in Q2 2025 was Bard Associates, an estimated $2.11K sold.

Based on aggregated 13F filings for Q2 2025.